Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

NVAX has a Moderate Buy rating on Wall Street based on two Buy, two Hold, and zero Sell ratings over the past three months. NVAX’s average price target of $14.25 implies a mammoth 113% upside ...

Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...

Respiratory syncytial virus (RSV) is a leading cause of infant hospitalization, with the greatest impact on infants under 6 months of age. Most RSV hospitalizations occur in healthy infants ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...

A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...